Preliminary safety assessment of sulphadoxine-pyrimethamine during intermittent presumptive treatment of pregnant women in a region with high prevalence of G6PD deficiency

International Journal of Risk and Safety in Medicine

Volumn 17, Issue 1-2, 2005, Pages 13-18

  Dodoo, A N O ^a   Gyansa Lutterodt, M ^b   Frempong, N ^b   Thompson, H ^a   Amofa, G ^c   Bart Plange, C ^c   Allotey, N K ^c   Eghan, K E ^d  

^a UNIVERSITY OF GHANA   (Ghana)

^b MINISTRY OF HEALTH   (Ghana)

^c GHANA HEALTH SERVICE   (Ghana)

^d Management Sciences for Health   (Ghana)

Author keywords

G6PD deficiency; Intermittent presumptive therapy; Sulfadoxine pyrimethamine

Indexed keywords

FANSIDAR;

ABDOMINAL PAIN; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG TOLERABILITY; FACE EDEMA; GHANA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE PERSONNEL; HUMAN; INDIGESTION; INSOMNIA; MALARIA; MALE; PATIENT CARE; PREGNANT WOMAN; PREVALENCE; PRURITUS; RASH; RISK ASSESSMENT; SKIN ULCER; VOMITING;

EID: 23944477108     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. C.T.A. Acquaye and J.H. Oldham, Variants of haemoglobin and glucose-6-phosphate dehydrogenase - I. Distribution in Southern Ghana, Ghana Med. J. 12 (1973), 412-418.
2. K.S. Chugh, A. Narang, L. Kumar, V. Sakhuja, V.N. Unni, R. Pirzada, N. Singh, B.J. Pereira and P.C. Singhal, Acute renal failure amongst children in a tropical environment, Int. J. Artif. Organs 10 (1987), 97-101.
3. P.E. Duffy and T.K. Mutabingwa, Drug combinations for malaria: time to ACT?, Lancet 363 (2004), 3-4.
4. A.M. van Eijk, J.G. Ayisi, F.O. ter Kuile, J.A. Otieno, A.O. Misore, J.O. Odondi, D.H. Rosen, P.A. Kager, R.W. Steketee and B.L. Nahlen, Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study, Trop. Med. Int. Health 9 (2004), 351-360.
5. J.P. van Geertruyden, F. Thomas, A. Erhart and U. D'Alessandro, The contribution of malaria in pregnancy to perinatal mortality, Am. J. Trop. Med. Hyg. 71(2 Suppl.) (2004), 35-40.
6. S. Jimah, Audit of antimalarial chemoprophylaxis in pregnancy. MSc Audit, Kwame Nkrumah University of Science and Technology, Kumasi, 2004.
7. Y. Kilinc and M. Kumi, Haemolytic crises due to glucose-6-phosphate dehydrogenase deficiency in the mid-southern region of Turkey, Acta Paediatr. Scand. 79 (1990), 1075-1079.
8. F.P. Mockenhaupt, J. Mandelkow, H. Till, S. Ehrhardt, T.A. Eggelte and U. Bienzle, Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency, Trop. Med. Int. Health 8 (2003), 118-124.
9. National Malaria Control Programme. Ghana National Malaria Policy, Ministry of Health/Ghana Health Service, 2004.
10. R.D. Newman, M.E. Parise, E. Slutsker, B. Nahlen and R.W. Steketee, Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum - endemic sub-Saharan Africa, Trop. Med. Int. Health 8 (2003), 488-506.
11. S.K. Owusu, A.K. Foli and F.I.D. Konotey-Ahulu, Frequency of glucose-6-phosphate dehydrogenase deficiency in typhoid fever in Ghana, Lancet 1 (1972), 320.
12. S.J. Rogerson, E. Chaluluka, M. Kanjala, P. Mkundika, C. Mhangoand and M.E. Molyneux, Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99, Trans. R. Soc. Trop. Med. Hyg. 94 (2000), 549-553.
13. K. Shannon and G.R. Buchanan, Severe hemolytic anemia in black children with glucose-6-phosphate dehydrogenase deficiency, Pediatrics 70 (1982), 364-369.
14. C.E. Shulman, E.K. Dorman, F. Cutts, K. Kawuondo, J.N. Bulmer, N. Peshu and K. Marsh, Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial, Lancet 353 (1999), 632-636.
15. The Roll Back Malaria Partnership. The Abuja Declaration and the Plan of Action, WHO/CDS/RBS/2000.17, 2000.